/assets/images/provider/photos/2837305.png)
TRT is safe when practiced like medicine.
It becomes risky when treated like a supplement business.
Here’s what responsible monitoring looks like.
Baseline labs should include:
CBC (to assess hematocrit)
CMP
Lipid panel
PSA (when age-appropriate)
LH/FSH
Estradiol
Thyroid function
This helps determine whether the cause is primary or secondary — and whether TRT is even appropriate.
Monitoring should include:
Hematocrit levels
Estradiol
Testosterone levels
Cardiovascular risk markers
If hematocrit rises above safe thresholds (often 54–55%), therapeutic phlebotomy may be required before continuing therapy.
This is not optional.
Abuse-level dosing
No lab monitoring
Ignoring sleep apnea
Ignoring obesity and insulin resistance
Ignoring elevated hematocrit
TRT does not increase cardiovascular risk when prescribed appropriately in properly selected patients. Poor practice increases risk.
TRT should always be part of a broader health strategy — not a shortcut.
If you’re considering testosterone therapy, make sure your provider treats it like medicine.